150 related articles for article (PubMed ID: 5096833)
1. Prevention of unintentional overexposure in topical psoralen treatment of vitiligo.
Parrish JA; Pathak MA; Fitzpatrick TB
Arch Dermatol; 1971 Sep; 104(3):281-3. PubMed ID: 5096833
[No Abstract] [Full Text] [Related]
2. [Practical dermatologic viewpoints on light protection and depigmentation].
Tronnier H; Hoppe-Seyler G
Asthet Med (Berl); 1968 Oct; 17(10):221-8. PubMed ID: 5306151
[No Abstract] [Full Text] [Related]
3. Hypertrichosis and hyperpigmentation with systemic psoralen treatment.
Singh G; Lal S
Br J Dermatol; 1967; 79(8):501-3. PubMed ID: 6039638
[No Abstract] [Full Text] [Related]
4. Topical and systemic approaches to photoprotection.
Fitzpatrick TB; Pathak MA; Parrish JA; Mathews-Roth M
Proc R Soc Med; 1971 Aug; 64(8):861-2. PubMed ID: 5569329
[No Abstract] [Full Text] [Related]
5. Photopigmentation with trioxsalen.
Kaidbey KH; Kligman AM
Arch Dermatol; 1974 May; 109(5):674-7. PubMed ID: 4828534
[No Abstract] [Full Text] [Related]
6. Drugs for pigmentary disorders.
Drug Ther Bull; 1968 Jan; 6(2):5-7. PubMed ID: 5639961
[No Abstract] [Full Text] [Related]
7. Psoralen phototherapeutic agents.
Becker SW
JAMA; 1967 Oct; 202(5):422-4. PubMed ID: 6072502
[No Abstract] [Full Text] [Related]
8. Calcipotriene and vitiligo.
Vásquez-López F; López-Escobar M; Pérez-Oliva N
Arch Dermatol; 2003 Dec; 139(12):1656-7. PubMed ID: 14676092
[No Abstract] [Full Text] [Related]
9. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
10. Vitiligo: new and emerging treatments.
Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
[TBL] [Abstract][Full Text] [Related]
11. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
12. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia].
Braĭtsev AV
Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363
[No Abstract] [Full Text] [Related]
13. [The prevention of photodermatoses].
Longhin S
Dermatol Int; 1965; 4(3):192-6. PubMed ID: 5877289
[No Abstract] [Full Text] [Related]
14. [Protective ointments against occupational photosensitization due to tar containing substances].
Wiskemann A; Krempin I
Berufsdermatosen; 1967 Aug; 15(4):208-12. PubMed ID: 4231941
[No Abstract] [Full Text] [Related]
15. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
[TBL] [Abstract][Full Text] [Related]
16. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
17. Sunscreens for chloasma.
Wolfe EM
JAMA; 1969 Jul; 209(1):112. PubMed ID: 5819253
[No Abstract] [Full Text] [Related]
18. [Furalen in the treatment of alopecia areata and vitiligo].
Skripkin IuK; Vinokurov IN; Borisenko KK; Ostrovskiĭ NN; Ukhova LS
Vestn Dermatol Venerol; 1972 Aug; 46(8):72-5. PubMed ID: 5056803
[No Abstract] [Full Text] [Related]
19. Calcipotriene and corticosteroid combination therapy for vitiligo.
Travis LB; Silverberg NB
Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
[TBL] [Abstract][Full Text] [Related]
20. [Amiodarone pigmentation].
Matheis H
Dermatologica; 1972; 145(5):304-18. PubMed ID: 4654410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
